NATALIE MILLER: Open Payments
NPI 1235578477 · FORT COLLINS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,615 in 58 payments from 20 companies in 2025. Trend: 2023 $825 · 2024 $1,743 · 2025 $1,615
Food & beverage: $1,515Education: $100
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 11 | $301 |
| Regeneron Healthcare Solutions, Inc. | 6 | $205 |
| ABBVIE INC. | 6 | $194 |
| Janssen Biotech, Inc. | 5 | $173 |
| Galderma Laboratories, L.P. | 2 | $120 |
| E.R. Squibb & Sons, L.L.C. | 1 | $89 |
| GENZYME CORPORATION | 3 | $62 |
| UCB, Inc. | 3 | $59 |
| Organon LLC | 4 | $52 |
| PFIZER INC. | 3 | $50 |
Products named: DUPIXENT, TREMFYA, SKYRIZI, COSENTYX, NEMLUVIO, Sotyktu, Bimzelx, RINVOQ.
Industry payments across CO — which companies pay providers there.
